![Graeme Currie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Graeme Martin Currie formerly worked at Alpha-5 Integrin LLC, as Chief Executive Officer from 2021 to 2022, Gilead Sciences, Inc., as Director-Clinical Research, PDL BioPharma, Inc., as Vice President-Clinical Operations, Rainier Therapeutics, Inc., as Chief Operating Officer from 2017 to 2019, Tolerion, Inc., as Chief Development Officer from 2019 to 2021, Lytix Biopharma AS, as Chief Development Officer from 2021 to 2023, and Pasithea Therapeutics Corp., as Chief Development Officer from 2022 to 2024.
Dr. Currie received his doctorate degree from the University of Aston.
Anciens postes connus de Graeme Currie
| Sociétés | Poste | Fin |
|---|---|---|
| PASITHEA THERAPEUTICS CORP. | Corporate Officer/Principal | 15/11/2024 |
| LYTIX BIOPHARMA ASA | Corporate Officer/Principal | 01/06/2023 |
Alpha-5 Integrin LLC
 Alpha-5 Integrin LLC Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody for the treatment of amyotrophic lateral sclerosis and neurodegenerative diseases | Directeur Général | 01/06/2022 |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Corporate Officer/Principal | 01/01/2021 |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Directeur des opérations | 01/01/2019 |
Formation de Graeme Currie
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Health Technology |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
Pasithea Therapeutics Corp.
 Pasithea Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for mental health disorders | Health Technology |
Alpha-5 Integrin LLC
Alpha-5 Integrin LLC Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody for the treatment of amyotrophic lateral sclerosis and neurodegenerative diseases | Health Technology |
